Lower Urinary Tract Symptoms (LUTS) and Sexual Function and Dysfunction

In recent years, the coexistence of sexual dysfunction (SD) and lower urinary tract symptoms (LUTS) has become a popular topic for researchers. Numerous clinical epidemiologic studies have been planned for this reason and have evaluated the relationship between these seemingly irrelevant urological conditions. The connection between SD and LUTS has already been acknowledged, and common pathophysiological pathways have been recognized. In this chapter was attempted to evaluate the impact on patient’s quality of life (QoL), common pathophysiological pathways and therapy aspects of this condition. SD and LUTS are common problems among the general population and affect a great percentage of urological patients. It is a subject that affects the community in social, financial, and psychological terms. In this case, research for new treatment options has been triggered as phosphodiesterase type 5 inhibitors established their role as the widely approved combination therapy.

• Publication year

  2019

• Venue

  Lower Urinary Tract Dysfunction - From Evidence to Clinical Practice

• Publication date

  2019-06-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.5772/INTECHOPEN.86827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Urologists’ attitudes to sexual complications of LUTS/BPH treatments

  2018cited by this paper
• Evaluation of Sexual Dysfunction, Lower Urinary Tract Symptoms and Quality of Life in Men With Obstructive Sleep Apnea Syndrome and the Efficacy of Continuous Positive Airway Pressure Therapy.

  2018cited by this paper
• Risk of Suicide After Cancer Diagnosis in England

  2018cited by this paper
• Effect of continuous positive airway pressure on nocturnal urine production in patients with obstructive sleep apnea syndrome

  2017cited by this paper
• How does lower urinary tract dysfunction affect sexual function in men and women? ICI‐RS 2015—Part 1

  2017cited by this paper
• Nonalcoholic Fatty Liver Disease is Associated with Erectile Dysfunction: A Prospective Pilot Study.

  2016cited by this paper
• Definitions of Sexual Dysfunctions in Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015.

  2016cited by this paper
• Effects of obstructive sleep apnea and its treatment over the erectile function: a systematic review

  2016cited by this paper
• Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study.

  2016cited by this paper
• The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review

  2016cited by this paper
• Diagnosing Sexual Dysfunction in Men and Women: Sexual History Taking and the Role of Symptom Scales and Questionnaires.

  2016cited by this paper
• Have rates of erectile dysfunction improved within the past 17 years after radical prostatectomy? A systematic analysis of the control arms of prospective randomized trials on penile rehabilitation

  2015cited by this paper
• Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.

  2015cited by this paper
• Metabolic Syndrome, Inflammation and Lower Urinary Tract Symptoms – Possible Translational Links

  2015cited by this paper
• Effect of surgical approach on erectile function recovery following bilateral nerve‐sparing radical prostatectomy: an evaluation utilising data from a randomised, double‐blind, double‐dummy multicentre trial of tadalafil vs placebo

  2015cited by this paper
• Male Sexual Dysfunction and Ankylosing Spondylitis: A Systematic Review and Metaanalysis

  2015cited by this paper
• Urgency and other lower urinary tract symptoms in men aged ≥ 40 years: a Belgian epidemiological survey using the ICIQ‐MLUTS questionnaire

  2015cited by this paper
• Metabolic syndrome and benign prostatic enlargement: a systematic review and meta‐analysis

  2015cited by this paper
• Sexual dysfunction in psoriasis: a systematic review

  2015cited by this paper
• Does this man with lower urinary tract symptoms have bladder outlet obstruction?: The Rational Clinical Examination: a systematic review.

  2014cited by this paper
• Pilot study of the clinical efficacy of ejaculatory hood sparing technique for ejaculation preservation in Holmium laser enucleation of the prostate

  2014cited by this paper
• Erectile Function Outcomes after Robot-Assisted Radical Prostatectomy: Is It Superior to Open Retropubic or Laparoscopic Approach?

  2014cited by this paper
• What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women

  2014cited by this paper
• Do we need a new definition of the overactive bladder syndrome? ICI‐RS 2013

  2014cited by this paper
• A systematic review of the association between erectile dysfunction and cardiovascular disease.

  2014cited by this paper
• The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and Its Potential Impact on Medical Therapy

  2014cited by this paper
• Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound.

  2013cited by this paper
• SOP: corpus cavernosum assessment (cavernosography/cavernosometry).

  2013cited by this paper
• Pelvic radiotherapy and sexual function in men and women.

  2013cited by this paper
• Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data

  2013cited by this paper
• Erectile dysfunction in the cardiovascular patient.

  2013cited by this paper
• One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice.

  2013cited by this paper
• Standard operating procedures for taking a sexual history.

  2013cited by this paper
• Modifying risk factors to prevent and treat erectile dysfunction.

  2013cited by this paper
• A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

  2012cited by this paper
• Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery.

  2012cited by this paper
• Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer

  2012cited by this paper
• Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.

  2012cited by this paper
• High‐intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer

  2012cited by this paper
• Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain.

  2012cited by this paper
• The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer.

  2012cited by this paper
• Effects of α1-Adrenoceptor Antagonists on Male Sexual Function

  2012cited by this paper
• Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.

  2011cited by this paper
• Update on AUA guideline on the management of benign prostatic hyperplasia.

  2011cited by this paper
• Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.

  2011cited by this paper
• Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

  2011cited by this paper
• The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis.

  2011cited by this paper
• 2272 EJACULATION-PRESERVING PHOTOSELECTIVE VAPORIZATION OF PROSTATE(EP-PVP): SIX YEARS EXPERIENCE FROM A MULTI-CENTRE STUDY

  2011cited by this paper
• Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.

  2011cited by this paper
• The DSM Diagnostic Criteria for Female Orgasmic Disorder

  2010cited by this paper
• Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract.

  2010cited by this paper
• Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats.

  2010cited by this paper
• Endocrine aspects of male sexual dysfunctions.

  2010cited by this paper
• Recommendations for the clinical evaluation of men and women with sexual dysfunction.

  2010cited by this paper
• Cardiovascular aspects of sexual medicine.

  2010cited by this paper
• The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.

  2010cited by this paper
• The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.

  2009cited by this paper
• Erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED.

  2009cited by this paper
• The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors.

  2009cited by this paper
• Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.

  2009cited by this paper
• The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.

  2008cited by this paper
• Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study.

  2008cited by this paper
• Core Lower Urinary Tract Symptom Score (CLSS) questionnaire: A reliable tool in the overall assessment of lower urinary tract symptoms

  2008cited by this paper
• Lower urinary tract symptoms and risk of prostate cancer: The HUNT 2 Cohort, Norway

  2008cited by this paper
• Quality of life and satisfaction with outcome among prostate-cancer survivors.

  2008cited by this paper
• Lower urinary tract symptoms revisited: a broader clinical perspective.

  2008cited by this paper
• Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.

  2008cited by this paper
• A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.

  2007cited by this paper
• Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

  2007cited by this paper
• Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.

  2007cited by this paper
• Characterization and functional role of androgen-dependent PDE5 activity in the bladder.

  2007cited by this paper
• Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up.

  2006cited by this paper
• The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the united states

  2006cited by this paper
• Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

  2006cited by this paper
• Critical Review of Guidelines for BPH Diagnosis and Treatment Strategy

  2006cited by this paper
• KTP Laser versus Transurethral Resection: Early Results of a Randomized Trial

  2006cited by this paper
• Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial.

  2006cited by this paper
• Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.

  2006cited by this paper
• Incidence rates of erectile dysfunction in the Dutch general population. Effects of definition, clinical relevance and duration of follow-up in the Krimpen Study

  2005cited by this paper
• Frequency volume charts in the assessment and evaluation of treatment: how should we use them?

  2004cited by this paper
• Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial.

  2004cited by this paper
• [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].

  2004cited by this paper
• The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

  2003cited by this paper
• Randomized Clinical Trial Comparing Transurethral Needle Ablation with Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia: Results at 18 Months

  2003cited by this paper
• Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

  2002cited by this paper
• Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence

  2001cited by this paper
• Scoring the short form ICSmaleSF questionnaire. International Continence Society.

  2000cited by this paper
• Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study.

  2000cited by this paper
• Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence

  2000cited by this paper
• SCORING THE SHORT FORM ICSmaleSF QUESTIONNAIRE

  2000cited by this paper
• Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’

  2000cited by this paper
• Hemodynamic Characterization of a Functional Erection

  1999cited by this paper
• Is transurethral resection of the prostate still justified?

  1999cited by this paper
• The process of care model for evaluation and treatment of erectile dysfunction

  1999cited by this paper
• Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test.

  1999cited by this paper
• A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.

  1998cited by this paper
• The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

  1997cited by this paper
• The effect of prostatectomy on symptom severity and quality of life.

  1996cited by this paper
• The value of a new symptom score (DAN-PSS) in diagnosing uro-dynamic infravesical obstruction in BPH.

  1993cited by this paper
• Validation of a new quality of life questionnaire for benign prostatic hyperplasia.

  1992cited by this paper

• Assessment of prevalence of sexual dysfunction in patients having lower urinary tract symptoms with benign prostatic hyperplasia and effect of various treatment modalities on sexual function

  2024cites this paper